Dr Ashwini Sharan and Cambridge Consultants provoked debate with a film, ‘A day in the life of a Parkinson’s patient in 2030’, which imagined seamless therapy enabled by smart active implants, surgical robotics, digital connectivity and AI
Should we be designing systems that autonomously control both accuracy and precision for the best outcome of the patient? Andy Savarese explores the questions and looks ahead as the role of surgical robotics evolves.
Photonics promises to revolutionise health monitoring. Here, Tom Watson explores the wider potential in personalised medicine – and provides insight into overcoming the key challenges that lie ahead.
The current state of in vitro diagnostics (IVDs) is no longer fit for purpose. In vitro diagnostics needs seismic change to improve patient outcomes and deliver economic benefits.
To decentralise, or not to decentralise, that is the question. This Web3 dilemma reflects the likely thoughts of current digital leaders who want to make the best use of their digital assets while maintaining trust in their data systems.
Cell and gene therapy is hailed as the future of 21st century medicine but is currently too expensive to be widely used. As a principal scientist in synthetic biology, Matthew Jones is part of a team addressing this issue in an ambitious project with exciting potential.